-
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Consensus Rating of "Hold" by Analysts
Источник: Buzz FX / 12 фев 2025 01:11:12 America/Chicago
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Consensus Rating of "Hold" by Analysts Written by MarketBeat February 12, 2025 Share Link copied to clipboard. Zentalis Pharmaceuticals, Inc. ( NASDAQ:ZNTL - Get Free Report ) has received
Read more...